nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—Exemestane—breast cancer	0.298	1	CrCtD
Conjugated Estrogens—Estradiol—Fulvestrant—breast cancer	0.0749	0.443	CrCrCtD
Conjugated Estrogens—SLCO1B1—breast cancer	0.0408	0.221	CbGaD
Conjugated Estrogens—Estropipate—Exemestane—breast cancer	0.0374	0.221	CrCrCtD
Conjugated Estrogens—ABCC1—breast cancer	0.0337	0.183	CbGaD
Conjugated Estrogens—COMT—breast cancer	0.0303	0.164	CbGaD
Conjugated Estrogens—Formestane—Exemestane—breast cancer	0.0292	0.172	CrCrCtD
Conjugated Estrogens—ESR2—breast cancer	0.0282	0.153	CbGaD
Conjugated Estrogens—Estrone—Exemestane—breast cancer	0.0277	0.164	CrCrCtD
Conjugated Estrogens—ESR2—Fulvestrant—breast cancer	0.0219	0.0999	CbGbCtD
Conjugated Estrogens—ABCG2—breast cancer	0.0177	0.0963	CbGaD
Conjugated Estrogens—ESR1—breast cancer	0.0174	0.0943	CbGaD
Conjugated Estrogens—ESR2—Raloxifene—breast cancer	0.013	0.0594	CbGbCtD
Conjugated Estrogens—ESR1—Fluoxymesterone—breast cancer	0.0121	0.0551	CbGbCtD
Conjugated Estrogens—ESR1—Toremifene—breast cancer	0.0121	0.0551	CbGbCtD
Conjugated Estrogens—ESR1—Fulvestrant—breast cancer	0.0112	0.0512	CbGbCtD
Conjugated Estrogens—CYP3A4—breast cancer	0.00887	0.0481	CbGaD
Conjugated Estrogens—ESR2—Tamoxifen—breast cancer	0.0086	0.0393	CbGbCtD
Conjugated Estrogens—ABCC11—Methotrexate—breast cancer	0.0075	0.0343	CbGbCtD
Conjugated Estrogens—ABCB1—breast cancer	0.00738	0.0401	CbGaD
Conjugated Estrogens—ABCC1—Idarubicin—breast cancer	0.0071	0.0324	CbGbCtD
Conjugated Estrogens—ESR1—Raloxifene—breast cancer	0.00666	0.0304	CbGbCtD
Conjugated Estrogens—SLCO1A2—Chlorambucil—breast cancer	0.00634	0.0289	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—breast cancer	0.00515	0.0235	CbGbCtD
Conjugated Estrogens—ESR1—Tamoxifen—breast cancer	0.0044	0.0201	CbGbCtD
Conjugated Estrogens—ABCC3—Fluorouracil—breast cancer	0.00375	0.0172	CbGbCtD
Conjugated Estrogens—SLCO1B3—Paclitaxel—breast cancer	0.00352	0.0161	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—breast cancer	0.00329	0.015	CbGbCtD
Conjugated Estrogens—ABCC1—Mitoxantrone—breast cancer	0.00305	0.0139	CbGbCtD
Conjugated Estrogens—ABCC4—Fluorouracil—breast cancer	0.00287	0.0131	CbGbCtD
Conjugated Estrogens—CYP1A2—Anastrozole—breast cancer	0.00258	0.0118	CbGbCtD
Conjugated Estrogens—SLCO1B3—Docetaxel—breast cancer	0.00255	0.0116	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—breast cancer	0.00247	0.0113	CbGbCtD
Conjugated Estrogens—ABCC1—Paclitaxel—breast cancer	0.00243	0.0111	CbGbCtD
Conjugated Estrogens—ABCC1—Irinotecan—breast cancer	0.0024	0.011	CbGbCtD
Conjugated Estrogens—CYP1A2—Toremifene—breast cancer	0.00236	0.0108	CbGbCtD
Conjugated Estrogens—ABCC2—Tamoxifen—breast cancer	0.00232	0.0106	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—breast cancer	0.00214	0.00976	CbGbCtD
Conjugated Estrogens—ABCC1—Vinblastine—breast cancer	0.00214	0.00975	CbGbCtD
Conjugated Estrogens—ABCG2—Tamoxifen—breast cancer	0.00209	0.00956	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—breast cancer	0.00207	0.00946	CbGbCtD
Conjugated Estrogens—ABCB1—Toremifene—breast cancer	0.00207	0.00944	CbGbCtD
Conjugated Estrogens—ABCG2—Mitoxantrone—breast cancer	0.00204	0.00933	CbGbCtD
Conjugated Estrogens—SLCO1B1—Irinotecan—breast cancer	0.00202	0.00924	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—breast cancer	0.00184	0.0084	CbGbCtD
Conjugated Estrogens—ABCC2—Paclitaxel—breast cancer	0.0018	0.00823	CbGbCtD
Conjugated Estrogens—CYP3A4—Exemestane—breast cancer	0.00179	0.00816	CbGbCtD
Conjugated Estrogens—ABCC2—Irinotecan—breast cancer	0.00178	0.00812	CbGbCtD
Conjugated Estrogens—ABCC1—Docetaxel—breast cancer	0.00176	0.00804	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—breast cancer	0.0017	0.00776	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—breast cancer	0.0017	0.00775	CbGbCtD
Conjugated Estrogens—ABCG2—Paclitaxel—breast cancer	0.00163	0.00744	CbGbCtD
Conjugated Estrogens—ABCG2—Irinotecan—breast cancer	0.00161	0.00734	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—breast cancer	0.00158	0.00723	CbGbCtD
Conjugated Estrogens—ABCC2—Vinblastine—breast cancer	0.00158	0.00722	CbGbCtD
Conjugated Estrogens—ABCG2—Fluorouracil—breast cancer	0.00154	0.00705	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—breast cancer	0.00153	0.007	CbGbCtD
Conjugated Estrogens—CYP3A4—Letrozole—breast cancer	0.00152	0.00694	CbGbCtD
Conjugated Estrogens—ABCB1—Lapatinib—breast cancer	0.00151	0.00689	CbGbCtD
Conjugated Estrogens—CYP3A4—Anastrozole—breast cancer	0.00135	0.00618	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—breast cancer	0.00131	0.00599	CbGbCtD
Conjugated Estrogens—ABCC2—Docetaxel—breast cancer	0.0013	0.00595	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—breast cancer	0.00127	0.00581	CbGbCtD
Conjugated Estrogens—CYP3A4—Toremifene—breast cancer	0.00124	0.00566	CbGbCtD
Conjugated Estrogens—ABCG2—Docetaxel—breast cancer	0.00118	0.00538	CbGbCtD
Conjugated Estrogens—CYP3A4—Fulvestrant—breast cancer	0.00115	0.00526	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—breast cancer	0.00113	0.00518	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—breast cancer	0.00107	0.00489	CbGbCtD
Conjugated Estrogens—CYP3A4—Thiotepa—breast cancer	0.00103	0.00469	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—breast cancer	0.000988	0.00451	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—breast cancer	0.000971	0.00444	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—breast cancer	0.000941	0.0043	CbGbCtD
Conjugated Estrogens—CYP3A4—Ixabepilone—breast cancer	0.000938	0.00429	CbGbCtD
Conjugated Estrogens—CYP3A4—Lapatinib—breast cancer	0.000903	0.00413	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—breast cancer	0.000878	0.00401	CbGbCtD
Conjugated Estrogens—CYP1A2—Tamoxifen—breast cancer	0.000863	0.00394	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—breast cancer	0.000851	0.00389	CbGbCtD
Conjugated Estrogens—ABCC11—mammary gland—breast cancer	0.000848	0.0463	CbGeAlD
Conjugated Estrogens—ABCB1—Vinorelbine—breast cancer	0.000836	0.00382	CbGbCtD
Conjugated Estrogens—ABCB1—Tamoxifen—breast cancer	0.000755	0.00345	CbGbCtD
Conjugated Estrogens—ABCB1—Mitoxantrone—breast cancer	0.000736	0.00336	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—breast cancer	0.000688	0.00314	CbGbCtD
Conjugated Estrogens—CYP3A4—Raloxifene—breast cancer	0.000684	0.00313	CbGbCtD
Conjugated Estrogens—ABCB1—Gemcitabine—breast cancer	0.00065	0.00297	CbGbCtD
Conjugated Estrogens—CYP1A2—Fluorouracil—breast cancer	0.000636	0.00291	CbGbCtD
Conjugated Estrogens—ABCB1—Paclitaxel—breast cancer	0.000587	0.00268	CbGbCtD
Conjugated Estrogens—ABCB1—Irinotecan—breast cancer	0.00058	0.00265	CbGbCtD
Conjugated Estrogens—ABCC11—embryo—breast cancer	0.000579	0.0316	CbGeAlD
Conjugated Estrogens—ABCB1—Vinblastine—breast cancer	0.000515	0.00235	CbGbCtD
Conjugated Estrogens—CYP3A4—Vinorelbine—breast cancer	0.000501	0.00229	CbGbCtD
Conjugated Estrogens—SLC51B—endometrium—breast cancer	0.000475	0.0259	CbGeAlD
Conjugated Estrogens—CYP3A4—Tamoxifen—breast cancer	0.000452	0.00207	CbGbCtD
Conjugated Estrogens—CYP3A4—Mitoxantrone—breast cancer	0.000441	0.00201	CbGbCtD
Conjugated Estrogens—ABCB1—Docetaxel—breast cancer	0.000425	0.00194	CbGbCtD
Conjugated Estrogens—SLC51B—adrenal gland—breast cancer	0.000384	0.021	CbGeAlD
Conjugated Estrogens—CYP3A4—Paclitaxel—breast cancer	0.000352	0.00161	CbGbCtD
Conjugated Estrogens—ABCC11—female reproductive system—breast cancer	0.000351	0.0192	CbGeAlD
Conjugated Estrogens—CYP3A4—Irinotecan—breast cancer	0.000347	0.00159	CbGbCtD
Conjugated Estrogens—SLC51B—endocrine gland—breast cancer	0.000333	0.0182	CbGeAlD
Conjugated Estrogens—SLCO4A1—mammary gland—breast cancer	0.000333	0.0182	CbGeAlD
Conjugated Estrogens—ABCC11—female gonad—breast cancer	0.000319	0.0174	CbGeAlD
Conjugated Estrogens—ABCB1—Doxorubicin—breast cancer	0.000317	0.00145	CbGbCtD
Conjugated Estrogens—CYP3A4—Vinblastine—breast cancer	0.000309	0.00141	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—breast cancer	0.000307	0.0014	CbGbCtD
Conjugated Estrogens—SLCO3A1—nipple—breast cancer	0.000302	0.0165	CbGeAlD
Conjugated Estrogens—ABCC11—endocrine gland—breast cancer	0.000297	0.0162	CbGeAlD
Conjugated Estrogens—ESR2—mammary gland—breast cancer	0.000295	0.0161	CbGeAlD
Conjugated Estrogens—SLCO1B1—mammary gland—breast cancer	0.000293	0.016	CbGeAlD
Conjugated Estrogens—SLC51A—female reproductive system—breast cancer	0.000282	0.0154	CbGeAlD
Conjugated Estrogens—SLCO4A1—nipple—breast cancer	0.000275	0.015	CbGeAlD
Conjugated Estrogens—SLC51A—adrenal gland—breast cancer	0.000275	0.015	CbGeAlD
Conjugated Estrogens—SLCO2B1—mammary gland—breast cancer	0.000259	0.0142	CbGeAlD
Conjugated Estrogens—CYP3A4—Docetaxel—breast cancer	0.000254	0.00116	CbGbCtD
Conjugated Estrogens—SLC51A—endocrine gland—breast cancer	0.000239	0.013	CbGeAlD
Conjugated Estrogens—COMT—nipple—breast cancer	0.000233	0.0127	CbGeAlD
Conjugated Estrogens—SLCO1B3—pituitary gland—breast cancer	0.000229	0.0125	CbGeAlD
Conjugated Estrogens—ESR1—mammary gland—breast cancer	0.000202	0.011	CbGeAlD
Conjugated Estrogens—Estradiol—GPER1—breast cancer	0.000196	0.111	CrCbGaD
Conjugated Estrogens—CYP3A4—Doxorubicin—breast cancer	0.00019	0.000867	CbGbCtD
Conjugated Estrogens—SLCO1C1—pituitary gland—breast cancer	0.000188	0.0103	CbGeAlD
Conjugated Estrogens—SLCO1C1—adipose tissue—breast cancer	0.000187	0.0102	CbGeAlD
Conjugated Estrogens—SLC10A1—female reproductive system—breast cancer	0.000183	0.00998	CbGeAlD
Conjugated Estrogens—SLCO1B3—endocrine gland—breast cancer	0.000177	0.00969	CbGeAlD
Conjugated Estrogens—SLC22A11—female reproductive system—breast cancer	0.000167	0.00912	CbGeAlD
Conjugated Estrogens—SLCO4A1—endometrium—breast cancer	0.000166	0.00908	CbGeAlD
Conjugated Estrogens—SLCO3A1—pituitary gland—breast cancer	0.000165	0.00902	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—breast cancer	0.000165	0.00901	CbGeAlD
Conjugated Estrogens—SLCO3A1—adipose tissue—breast cancer	0.000165	0.00898	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—breast cancer	0.000164	0.00898	CbGeAlD
Conjugated Estrogens—ABCC1—nipple—breast cancer	0.000162	0.00884	CbGeAlD
Conjugated Estrogens—SLC10A1—endocrine gland—breast cancer	0.000155	0.00845	CbGeAlD
Conjugated Estrogens—SLCO3A1—female reproductive system—breast cancer	0.000151	0.00826	CbGeAlD
Conjugated Estrogens—SLCO4A1—pituitary gland—breast cancer	0.000151	0.00822	CbGeAlD
Conjugated Estrogens—SLCO4A1—adipose tissue—breast cancer	0.00015	0.00818	CbGeAlD
Conjugated Estrogens—COMT—skin of body—breast cancer	0.000149	0.00814	CbGeAlD
Conjugated Estrogens—SLCO3A1—adrenal gland—breast cancer	0.000148	0.00806	CbGeAlD
Conjugated Estrogens—ESR2—endometrium—breast cancer	0.000148	0.00805	CbGeAlD
Conjugated Estrogens—SLCO1C1—endocrine gland—breast cancer	0.000146	0.00794	CbGeAlD
Conjugated Estrogens—SLC22A11—endocrine gland—breast cancer	0.000141	0.00772	CbGeAlD
Conjugated Estrogens—COMT—endometrium—breast cancer	0.000141	0.00768	CbGeAlD
Conjugated Estrogens—ESR1—embryo—breast cancer	0.000138	0.00754	CbGeAlD
Conjugated Estrogens—SLCO4A1—female reproductive system—breast cancer	0.000138	0.00752	CbGeAlD
Conjugated Estrogens—SLCO3A1—female gonad—breast cancer	0.000138	0.00751	CbGeAlD
Conjugated Estrogens—ESR2—uterus—breast cancer	0.000136	0.00742	CbGeAlD
Conjugated Estrogens—SLCO4A1—adrenal gland—breast cancer	0.000134	0.00734	CbGeAlD
Conjugated Estrogens—ESR2—pituitary gland—breast cancer	0.000133	0.00729	CbGeAlD
Conjugated Estrogens—COMT—uterus—breast cancer	0.00013	0.00707	CbGeAlD
Conjugated Estrogens—CYP1A2—nipple—breast cancer	0.000129	0.00704	CbGeAlD
Conjugated Estrogens—SLCO3A1—endocrine gland—breast cancer	0.000128	0.00699	CbGeAlD
Conjugated Estrogens—COMT—pituitary gland—breast cancer	0.000127	0.00695	CbGeAlD
Conjugated Estrogens—COMT—adipose tissue—breast cancer	0.000127	0.00692	CbGeAlD
Conjugated Estrogens—Estradiol—ESRRA—breast cancer	0.000127	0.0717	CrCbGaD
Conjugated Estrogens—ABCC3—adipose tissue—breast cancer	0.000125	0.00683	CbGeAlD
Conjugated Estrogens—ESR2—female reproductive system—breast cancer	0.000122	0.00667	CbGeAlD
Conjugated Estrogens—SLCO1B1—female reproductive system—breast cancer	0.000121	0.00662	CbGeAlD
Conjugated Estrogens—SLCO2B1—uterus—breast cancer	0.000119	0.00651	CbGeAlD
Conjugated Estrogens—ESR2—adrenal gland—breast cancer	0.000119	0.00651	CbGeAlD
Conjugated Estrogens—SLCO2B1—adipose tissue—breast cancer	0.000117	0.00637	CbGeAlD
Conjugated Estrogens—SLCO4A1—endocrine gland—breast cancer	0.000117	0.00637	CbGeAlD
Conjugated Estrogens—COMT—female reproductive system—breast cancer	0.000116	0.00636	CbGeAlD
Conjugated Estrogens—ABCC3—female reproductive system—breast cancer	0.000115	0.00628	CbGeAlD
Conjugated Estrogens—COMT—adrenal gland—breast cancer	0.000114	0.00621	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—breast cancer	0.000113	0.00615	CbGeAlD
Conjugated Estrogens—ABCC3—adrenal gland—breast cancer	0.000112	0.00613	CbGeAlD
Conjugated Estrogens—ESR2—female gonad—breast cancer	0.000111	0.00607	CbGeAlD
Conjugated Estrogens—COMT—bone marrow—breast cancer	0.00011	0.006	CbGeAlD
Conjugated Estrogens—Equilin—SHBG—breast cancer	0.000109	0.0616	CrCbGaD
Conjugated Estrogens—SLCO2B1—female reproductive system—breast cancer	0.000107	0.00585	CbGeAlD
Conjugated Estrogens—COMT—female gonad—breast cancer	0.000106	0.00579	CbGeAlD
Conjugated Estrogens—ABCC4—uterus—breast cancer	0.000106	0.00577	CbGeAlD
Conjugated Estrogens—ABCC3—female gonad—breast cancer	0.000105	0.00572	CbGeAlD
Conjugated Estrogens—SLCO2B1—adrenal gland—breast cancer	0.000105	0.00571	CbGeAlD
Conjugated Estrogens—ESR2—endocrine gland—breast cancer	0.000103	0.00565	CbGeAlD
Conjugated Estrogens—ABCC4—adipose tissue—breast cancer	0.000103	0.00564	CbGeAlD
Conjugated Estrogens—SLCO1B1—endocrine gland—breast cancer	0.000103	0.0056	CbGeAlD
Conjugated Estrogens—ESR1—endometrium—breast cancer	0.000101	0.00552	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—breast cancer	0.000101	0.00549	CbGeAlD
Conjugated Estrogens—COMT—endocrine gland—breast cancer	9.86e-05	0.00538	CbGeAlD
Conjugated Estrogens—ABCC1—endometrium—breast cancer	9.77e-05	0.00534	CbGeAlD
Conjugated Estrogens—SLCO2B1—female gonad—breast cancer	9.76e-05	0.00533	CbGeAlD
Conjugated Estrogens—ABCC3—endocrine gland—breast cancer	9.74e-05	0.00532	CbGeAlD
Conjugated Estrogens—ABCC4—female reproductive system—breast cancer	9.5e-05	0.00518	CbGeAlD
Conjugated Estrogens—ESR1—uterus—breast cancer	9.31e-05	0.00508	CbGeAlD
Conjugated Estrogens—ABCC4—adrenal gland—breast cancer	9.27e-05	0.00506	CbGeAlD
Conjugated Estrogens—ABCC2—female reproductive system—breast cancer	9.19e-05	0.00502	CbGeAlD
Conjugated Estrogens—ESR1—pituitary gland—breast cancer	9.14e-05	0.00499	CbGeAlD
Conjugated Estrogens—ESR1—adipose tissue—breast cancer	9.1e-05	0.00497	CbGeAlD
Conjugated Estrogens—SLCO2B1—endocrine gland—breast cancer	9.07e-05	0.00495	CbGeAlD
Conjugated Estrogens—ABCC1—uterus—breast cancer	9.01e-05	0.00492	CbGeAlD
Conjugated Estrogens—ABCC2—adrenal gland—breast cancer	8.97e-05	0.0049	CbGeAlD
Conjugated Estrogens—ABCC4—bone marrow—breast cancer	8.96e-05	0.00489	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—breast cancer	8.85e-05	0.00483	CbGeAlD
Conjugated Estrogens—ABCC1—pituitary gland—breast cancer	8.84e-05	0.00483	CbGeAlD
Conjugated Estrogens—ABCC1—adipose tissue—breast cancer	8.81e-05	0.00481	CbGeAlD
Conjugated Estrogens—ABCC4—female gonad—breast cancer	8.64e-05	0.00472	CbGeAlD
Conjugated Estrogens—ESR1—female reproductive system—breast cancer	8.37e-05	0.00457	CbGeAlD
Conjugated Estrogens—SLCO1A2—endocrine gland—breast cancer	8.35e-05	0.00456	CbGeAlD
Conjugated Estrogens—ESR1—adrenal gland—breast cancer	8.17e-05	0.00446	CbGeAlD
Conjugated Estrogens—ABCG2—endometrium—breast cancer	8.09e-05	0.00442	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—breast cancer	8.06e-05	0.0044	CbGeAlD
Conjugated Estrogens—ABCC4—endocrine gland—breast cancer	8.04e-05	0.00439	CbGeAlD
Conjugated Estrogens—ABCC1—adrenal gland—breast cancer	7.9e-05	0.00431	CbGeAlD
Conjugated Estrogens—ABCC2—endocrine gland—breast cancer	7.78e-05	0.00425	CbGeAlD
Conjugated Estrogens—ESR1—female gonad—breast cancer	7.62e-05	0.00416	CbGeAlD
Conjugated Estrogens—Estriol—ESR2—breast cancer	7.48e-05	0.0424	CrCbGaD
Conjugated Estrogens—ABCG2—uterus—breast cancer	7.46e-05	0.00407	CbGeAlD
Conjugated Estrogens—ABCC1—female gonad—breast cancer	7.37e-05	0.00402	CbGeAlD
Conjugated Estrogens—ABCG2—pituitary gland—breast cancer	7.32e-05	0.004	CbGeAlD
Conjugated Estrogens—ABCG2—adipose tissue—breast cancer	7.29e-05	0.00398	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—breast cancer	7.15e-05	0.0039	CbGeAlD
Conjugated Estrogens—ESR1—endocrine gland—breast cancer	7.08e-05	0.00387	CbGeAlD
Conjugated Estrogens—Quinestrol—ESR1—breast cancer	6.97e-05	0.0395	CrCbGaD
Conjugated Estrogens—Estramustine—ESR2—breast cancer	6.95e-05	0.0394	CrCbGaD
Conjugated Estrogens—Estriol—SHBG—breast cancer	6.82e-05	0.0386	CrCbGaD
Conjugated Estrogens—COMT—lymph node—breast cancer	6.81e-05	0.00372	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—breast cancer	6.73e-05	0.00367	CbGeAlD
Conjugated Estrogens—ABCG2—adrenal gland—breast cancer	6.54e-05	0.00357	CbGeAlD
Conjugated Estrogens—Exemestane—CYP19A1—breast cancer	6.44e-05	0.0365	CrCbGaD
Conjugated Estrogens—ABCG2—bone marrow—breast cancer	6.33e-05	0.00346	CbGeAlD
Conjugated Estrogens—SLCO2B1—lymph node—breast cancer	6.27e-05	0.00342	CbGeAlD
Conjugated Estrogens—ABCG2—female gonad—breast cancer	6.1e-05	0.00333	CbGeAlD
Conjugated Estrogens—Estropipate—ESR2—breast cancer	5.72e-05	0.0324	CrCbGaD
Conjugated Estrogens—ABCC4—lymph node—breast cancer	5.55e-05	0.00303	CbGeAlD
Conjugated Estrogens—CYP1A2—endocrine gland—breast cancer	5.46e-05	0.00298	CbGeAlD
Conjugated Estrogens—ABCB1—embryo—breast cancer	5.45e-05	0.00298	CbGeAlD
Conjugated Estrogens—ABCC2—lymph node—breast cancer	5.38e-05	0.00294	CbGeAlD
Conjugated Estrogens—Mestranol—ESR1—breast cancer	5.28e-05	0.0299	CrCbGaD
Conjugated Estrogens—Estropipate—SHBG—breast cancer	5.22e-05	0.0295	CrCbGaD
Conjugated Estrogens—Estrone—SLCO1B1—breast cancer	5.14e-05	0.0291	CrCbGaD
Conjugated Estrogens—ESR1—lymph node—breast cancer	4.9e-05	0.00267	CbGeAlD
Conjugated Estrogens—ABCC1—lymph node—breast cancer	4.74e-05	0.00259	CbGeAlD
Conjugated Estrogens—CYP3A4—female reproductive system—breast cancer	4.67e-05	0.00255	CbGeAlD
Conjugated Estrogens—Estriol—ESR1—breast cancer	4.61e-05	0.0261	CrCbGaD
Conjugated Estrogens—ABCB1—epithelium—breast cancer	4.45e-05	0.00243	CbGeAlD
Conjugated Estrogens—Estramustine—ESR1—breast cancer	4.28e-05	0.0243	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ESR2—breast cancer	4.09e-05	0.0231	CrCbGaD
Conjugated Estrogens—ABCB1—endometrium—breast cancer	3.99e-05	0.00218	CbGeAlD
Conjugated Estrogens—CYP3A4—endocrine gland—breast cancer	3.95e-05	0.00216	CbGeAlD
Conjugated Estrogens—ABCG2—lymph node—breast cancer	3.92e-05	0.00214	CbGeAlD
Conjugated Estrogens—Estradiol—SLCO1B1—breast cancer	3.9e-05	0.0221	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—SHBG—breast cancer	3.73e-05	0.0211	CrCbGaD
Conjugated Estrogens—ABCB1—uterus—breast cancer	3.68e-05	0.00201	CbGeAlD
Conjugated Estrogens—ABCB1—pituitary gland—breast cancer	3.61e-05	0.00197	CbGeAlD
Conjugated Estrogens—ABCB1—adipose tissue—breast cancer	3.6e-05	0.00196	CbGeAlD
Conjugated Estrogens—Estrone—ESR2—breast cancer	3.56e-05	0.0202	CrCbGaD
Conjugated Estrogens—Estropipate—ESR1—breast cancer	3.52e-05	0.02	CrCbGaD
Conjugated Estrogens—ABCB1—female reproductive system—breast cancer	3.31e-05	0.0018	CbGeAlD
Conjugated Estrogens—Estrone—SHBG—breast cancer	3.25e-05	0.0184	CrCbGaD
Conjugated Estrogens—Estrone—CYP1B1—breast cancer	3.25e-05	0.0184	CrCbGaD
Conjugated Estrogens—ABCB1—adrenal gland—breast cancer	3.23e-05	0.00176	CbGeAlD
Conjugated Estrogens—ABCB1—bone marrow—breast cancer	3.12e-05	0.0017	CbGeAlD
Conjugated Estrogens—Exemestane—CYP3A4—breast cancer	3.02e-05	0.0171	CrCbGaD
Conjugated Estrogens—ABCB1—female gonad—breast cancer	3.01e-05	0.00164	CbGeAlD
Conjugated Estrogens—ABCB1—endocrine gland—breast cancer	2.8e-05	0.00153	CbGeAlD
Conjugated Estrogens—Estradiol—ESR2—breast cancer	2.7e-05	0.0153	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ESR1—breast cancer	2.52e-05	0.0143	CrCbGaD
Conjugated Estrogens—Estradiol—SHBG—breast cancer	2.46e-05	0.0139	CrCbGaD
Conjugated Estrogens—Estradiol—CYP1B1—breast cancer	2.46e-05	0.0139	CrCbGaD
Conjugated Estrogens—Estrone—ABCG2—breast cancer	2.24e-05	0.0127	CrCbGaD
Conjugated Estrogens—Estrone—ESR1—breast cancer	2.19e-05	0.0124	CrCbGaD
Conjugated Estrogens—Estramustine—CYP3A4—breast cancer	2.19e-05	0.0124	CrCbGaD
Conjugated Estrogens—Estradiol—AR—breast cancer	2.16e-05	0.0122	CrCbGaD
Conjugated Estrogens—Estriol—ABCB1—breast cancer	1.96e-05	0.0111	CrCbGaD
Conjugated Estrogens—ABCB1—lymph node—breast cancer	1.93e-05	0.00106	CbGeAlD
Conjugated Estrogens—Estramustine—ABCB1—breast cancer	1.82e-05	0.0103	CrCbGaD
Conjugated Estrogens—Estropipate—CYP3A4—breast cancer	1.8e-05	0.0102	CrCbGaD
Conjugated Estrogens—Estrone—CYP1A1—breast cancer	1.75e-05	0.00993	CrCbGaD
Conjugated Estrogens—Estradiol—ABCG2—breast cancer	1.7e-05	0.00961	CrCbGaD
Conjugated Estrogens—Estradiol—ESR1—breast cancer	1.66e-05	0.00941	CrCbGaD
Conjugated Estrogens—Estropipate—ALB—breast cancer	1.57e-05	0.00889	CrCbGaD
Conjugated Estrogens—Estradiol—CYP1A1—breast cancer	1.33e-05	0.00753	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—CYP3A4—breast cancer	1.28e-05	0.00728	CrCbGaD
Conjugated Estrogens—Estrone—CYP3A4—breast cancer	1.12e-05	0.00634	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ABCB1—breast cancer	1.07e-05	0.00606	CrCbGaD
Conjugated Estrogens—Estrone—ALB—breast cancer	9.76e-06	0.00553	CrCbGaD
Conjugated Estrogens—Estrone—ABCB1—breast cancer	9.32e-06	0.00528	CrCbGaD
Conjugated Estrogens—Estradiol—CYP3A4—breast cancer	8.48e-06	0.0048	CrCbGaD
Conjugated Estrogens—Headache—Mitoxantrone—breast cancer	7.52e-06	0.000113	CcSEcCtD
Conjugated Estrogens—Headache—Irinotecan—breast cancer	7.52e-06	0.000113	CcSEcCtD
Conjugated Estrogens—Hypotension—Capecitabine—breast cancer	7.51e-06	0.000113	CcSEcCtD
Conjugated Estrogens—Insomnia—Docetaxel—breast cancer	7.51e-06	0.000113	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Docetaxel—breast cancer	7.46e-06	0.000112	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—breast cancer	7.45e-06	0.000112	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—breast cancer	7.44e-06	0.000112	CcSEcCtD
Conjugated Estrogens—Vomiting—Gemcitabine—breast cancer	7.44e-06	0.000112	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Docetaxel—breast cancer	7.4e-06	0.000111	CcSEcCtD
Conjugated Estrogens—Estradiol—ALB—breast cancer	7.4e-06	0.00419	CrCbGaD
Conjugated Estrogens—Somnolence—Docetaxel—breast cancer	7.38e-06	0.000111	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—breast cancer	7.38e-06	0.000111	CcSEcCtD
Conjugated Estrogens—Rash—Gemcitabine—breast cancer	7.38e-06	0.000111	CcSEcCtD
Conjugated Estrogens—Dermatitis—Gemcitabine—breast cancer	7.37e-06	0.000111	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—breast cancer	7.37e-06	0.000111	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—breast cancer	7.33e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—breast cancer	7.33e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Headache—Gemcitabine—breast cancer	7.33e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Capecitabine—breast cancer	7.32e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—breast cancer	7.32e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Vomiting—Fluorouracil—breast cancer	7.31e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—breast cancer	7.31e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Docetaxel—breast cancer	7.31e-06	0.00011	CcSEcCtD
Conjugated Estrogens—Insomnia—Capecitabine—breast cancer	7.27e-06	0.000109	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—breast cancer	7.26e-06	0.000109	CcSEcCtD
Conjugated Estrogens—Rash—Fluorouracil—breast cancer	7.25e-06	0.000109	CcSEcCtD
Conjugated Estrogens—Dermatitis—Fluorouracil—breast cancer	7.25e-06	0.000109	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—breast cancer	7.24e-06	0.000109	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Capecitabine—breast cancer	7.22e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Docetaxel—breast cancer	7.22e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Paclitaxel—breast cancer	7.22e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Headache—Fluorouracil—breast cancer	7.21e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—breast cancer	7.19e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—breast cancer	7.18e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Docetaxel—breast cancer	7.17e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Capecitabine—breast cancer	7.17e-06	0.000108	CcSEcCtD
Conjugated Estrogens—Fatigue—Docetaxel—breast cancer	7.16e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—breast cancer	7.15e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Nausea—Mitoxantrone—breast cancer	7.13e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Nausea—Irinotecan—breast cancer	7.13e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—breast cancer	7.12e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—breast cancer	7.1e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Constipation—Docetaxel—breast cancer	7.1e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Pain—Docetaxel—breast cancer	7.1e-06	0.000107	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—breast cancer	7.09e-06	0.000106	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Capecitabine—breast cancer	7.08e-06	0.000106	CcSEcCtD
Conjugated Estrogens—Estradiol—ABCB1—breast cancer	7.06e-06	0.004	CrCbGaD
Conjugated Estrogens—Arrhythmia—Epirubicin—breast cancer	7.04e-06	0.000106	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—breast cancer	7.03e-06	0.000105	CcSEcCtD
Conjugated Estrogens—Asthenia—Paclitaxel—breast cancer	7.03e-06	0.000105	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Capecitabine—breast cancer	6.99e-06	0.000105	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—breast cancer	6.97e-06	0.000105	CcSEcCtD
Conjugated Estrogens—Nausea—Gemcitabine—breast cancer	6.95e-06	0.000104	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Capecitabine—breast cancer	6.94e-06	0.000104	CcSEcCtD
Conjugated Estrogens—Fatigue—Capecitabine—breast cancer	6.93e-06	0.000104	CcSEcCtD
Conjugated Estrogens—Pruritus—Paclitaxel—breast cancer	6.93e-06	0.000104	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—breast cancer	6.91e-06	0.000104	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—breast cancer	6.91e-06	0.000104	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—breast cancer	6.9e-06	0.000103	CcSEcCtD
Conjugated Estrogens—Pain—Capecitabine—breast cancer	6.87e-06	0.000103	CcSEcCtD
Conjugated Estrogens—Constipation—Capecitabine—breast cancer	6.87e-06	0.000103	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—breast cancer	6.86e-06	0.000103	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—breast cancer	6.86e-06	0.000103	CcSEcCtD
Conjugated Estrogens—Nausea—Fluorouracil—breast cancer	6.83e-06	0.000103	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—breast cancer	6.82e-06	0.000102	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Docetaxel—breast cancer	6.79e-06	0.000102	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—breast cancer	6.77e-06	0.000102	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—breast cancer	6.76e-06	0.000101	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—breast cancer	6.73e-06	0.000101	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—breast cancer	6.72e-06	0.000101	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Paclitaxel—breast cancer	6.7e-06	0.000101	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—breast cancer	6.66e-06	0.0001	CcSEcCtD
Conjugated Estrogens—Back pain—Epirubicin—breast cancer	6.64e-06	9.96e-05	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—breast cancer	6.62e-06	9.93e-05	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—breast cancer	6.6e-06	9.9e-05	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—breast cancer	6.59e-06	9.89e-05	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—breast cancer	6.59e-06	9.89e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Capecitabine—breast cancer	6.57e-06	9.86e-05	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—breast cancer	6.57e-06	9.86e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Docetaxel—breast cancer	6.56e-06	9.85e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Docetaxel—breast cancer	6.56e-06	9.85e-05	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—breast cancer	6.52e-06	9.78e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Paclitaxel—breast cancer	6.48e-06	9.72e-05	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—breast cancer	6.47e-06	9.7e-05	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—breast cancer	6.45e-06	9.67e-05	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—breast cancer	6.4e-06	9.6e-05	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—breast cancer	6.39e-06	9.59e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Capecitabine—breast cancer	6.39e-06	9.58e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Capecitabine—breast cancer	6.36e-06	9.54e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Capecitabine—breast cancer	6.36e-06	9.54e-05	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—breast cancer	6.35e-06	9.53e-05	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—breast cancer	6.35e-06	9.53e-05	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—breast cancer	6.35e-06	9.53e-05	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—breast cancer	6.26e-06	9.39e-05	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—breast cancer	6.24e-06	9.37e-05	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—breast cancer	6.24e-06	9.37e-05	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—breast cancer	6.24e-06	9.37e-05	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—breast cancer	6.23e-06	9.35e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Paclitaxel—breast cancer	6.23e-06	9.35e-05	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Doxorubicin—breast cancer	6.22e-06	9.33e-05	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.2e-06	9.3e-05	CcSEcCtD
Conjugated Estrogens—Rash—Paclitaxel—breast cancer	6.18e-06	9.27e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Paclitaxel—breast cancer	6.17e-06	9.26e-05	CcSEcCtD
Conjugated Estrogens—Nervousness—Doxorubicin—breast cancer	6.17e-06	9.25e-05	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—breast cancer	6.17e-06	9.25e-05	CcSEcCtD
Conjugated Estrogens—Syncope—Epirubicin—breast cancer	6.15e-06	9.23e-05	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—breast cancer	6.14e-06	9.22e-05	CcSEcCtD
Conjugated Estrogens—Headache—Paclitaxel—breast cancer	6.14e-06	9.21e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Docetaxel—breast cancer	6.12e-06	9.18e-05	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—breast cancer	6.1e-06	9.16e-05	CcSEcCtD
Conjugated Estrogens—Palpitations—Epirubicin—breast cancer	6.06e-06	9.1e-05	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Epirubicin—breast cancer	6.03e-06	9.05e-05	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—breast cancer	5.99e-06	8.99e-05	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—breast cancer	5.98e-06	8.98e-05	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—breast cancer	5.98e-06	8.98e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Docetaxel—breast cancer	5.96e-06	8.94e-05	CcSEcCtD
Conjugated Estrogens—Convulsion—Epirubicin—breast cancer	5.95e-06	8.92e-05	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—breast cancer	5.95e-06	8.92e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Capecitabine—breast cancer	5.92e-06	8.89e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Docetaxel—breast cancer	5.87e-06	8.81e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—breast cancer	5.87e-06	8.81e-05	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—breast cancer	5.84e-06	8.77e-05	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—breast cancer	5.84e-06	8.77e-05	CcSEcCtD
Conjugated Estrogens—Chest pain—Epirubicin—breast cancer	5.84e-06	8.77e-05	CcSEcCtD
Conjugated Estrogens—Anxiety—Epirubicin—breast cancer	5.82e-06	8.74e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Paclitaxel—breast cancer	5.82e-06	8.73e-05	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—breast cancer	5.81e-06	8.72e-05	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.8e-06	8.71e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—breast cancer	5.79e-06	8.68e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Capecitabine—breast cancer	5.77e-06	8.65e-05	CcSEcCtD
Conjugated Estrogens—Vertigo—Doxorubicin—breast cancer	5.7e-06	8.56e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—breast cancer	5.7e-06	8.56e-05	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—breast cancer	5.69e-06	8.54e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Capecitabine—breast cancer	5.69e-06	8.53e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Docetaxel—breast cancer	5.68e-06	8.52e-05	CcSEcCtD
Conjugated Estrogens—Palpitations—Doxorubicin—breast cancer	5.61e-06	8.42e-05	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—breast cancer	5.6e-06	8.4e-05	CcSEcCtD
Conjugated Estrogens—Oedema—Epirubicin—breast cancer	5.6e-06	8.4e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—breast cancer	5.59e-06	8.39e-05	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—breast cancer	5.58e-06	8.37e-05	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—breast cancer	5.56e-06	8.35e-05	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—breast cancer	5.54e-06	8.31e-05	CcSEcCtD
Conjugated Estrogens—Shock—Epirubicin—breast cancer	5.51e-06	8.27e-05	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—breast cancer	5.5e-06	8.25e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Capecitabine—breast cancer	5.5e-06	8.25e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—breast cancer	5.49e-06	8.24e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Docetaxel—breast cancer	5.49e-06	8.24e-05	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—breast cancer	5.47e-06	8.2e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—breast cancer	5.45e-06	8.18e-05	CcSEcCtD
Conjugated Estrogens—Skin disorder—Epirubicin—breast cancer	5.44e-06	8.16e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—breast cancer	5.41e-06	8.12e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—breast cancer	5.41e-06	8.12e-05	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—breast cancer	5.41e-06	8.11e-05	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—breast cancer	5.41e-06	8.11e-05	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—breast cancer	5.41e-06	8.11e-05	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—breast cancer	5.39e-06	8.08e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—breast cancer	5.37e-06	8.06e-05	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.37e-06	8.06e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Epirubicin—breast cancer	5.34e-06	8.01e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—breast cancer	5.34e-06	8.01e-05	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—breast cancer	5.32e-06	7.98e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Capecitabine—breast cancer	5.32e-06	7.98e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Docetaxel—breast cancer	5.28e-06	7.92e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—breast cancer	5.27e-06	7.9e-05	CcSEcCtD
Conjugated Estrogens—Rash—Docetaxel—breast cancer	5.24e-06	7.86e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Epirubicin—breast cancer	5.23e-06	7.85e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Docetaxel—breast cancer	5.23e-06	7.85e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—breast cancer	5.2e-06	7.81e-05	CcSEcCtD
Conjugated Estrogens—Headache—Docetaxel—breast cancer	5.2e-06	7.81e-05	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—breast cancer	5.18e-06	7.78e-05	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—breast cancer	5.18e-06	7.78e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—breast cancer	5.17e-06	7.75e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—breast cancer	5.16e-06	7.74e-05	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—breast cancer	5.15e-06	7.72e-05	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—breast cancer	5.12e-06	7.68e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Capecitabine—breast cancer	5.11e-06	7.67e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—breast cancer	5.1e-06	7.66e-05	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—breast cancer	5.1e-06	7.65e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—breast cancer	5.08e-06	7.63e-05	CcSEcCtD
Conjugated Estrogens—Rash—Capecitabine—breast cancer	5.07e-06	7.61e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Epirubicin—breast cancer	5.07e-06	7.6e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Capecitabine—breast cancer	5.06e-06	7.6e-05	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—breast cancer	5.06e-06	7.59e-05	CcSEcCtD
Conjugated Estrogens—Headache—Capecitabine—breast cancer	5.04e-06	7.56e-05	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—breast cancer	5.03e-06	7.55e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—breast cancer	5.03e-06	7.55e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—breast cancer	5.01e-06	7.52e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—breast cancer	4.99e-06	7.49e-05	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—breast cancer	4.98e-06	7.47e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Doxorubicin—breast cancer	4.94e-06	7.41e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Docetaxel—breast cancer	4.93e-06	7.4e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—breast cancer	4.93e-06	7.4e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—breast cancer	4.89e-06	7.34e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Epirubicin—breast cancer	4.87e-06	7.31e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Doxorubicin—breast cancer	4.84e-06	7.27e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—breast cancer	4.84e-06	7.26e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—breast cancer	4.83e-06	7.25e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Epirubicin—breast cancer	4.79e-06	7.19e-05	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—breast cancer	4.79e-06	7.19e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Capecitabine—breast cancer	4.78e-06	7.17e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—breast cancer	4.75e-06	7.13e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—breast cancer	4.73e-06	7.1e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—breast cancer	4.73e-06	7.1e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.72e-06	7.08e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Doxorubicin—breast cancer	4.69e-06	7.03e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Doxorubicin—breast cancer	4.65e-06	6.98e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—breast cancer	4.62e-06	6.93e-05	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—breast cancer	4.61e-06	6.91e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—breast cancer	4.58e-06	6.87e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—breast cancer	4.56e-06	6.84e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—breast cancer	4.5e-06	6.76e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—breast cancer	4.47e-06	6.71e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—breast cancer	4.47e-06	6.7e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Epirubicin—breast cancer	4.45e-06	6.68e-05	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—breast cancer	4.43e-06	6.65e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—breast cancer	4.43e-06	6.65e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—breast cancer	4.43e-06	6.64e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—breast cancer	4.43e-06	6.64e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—breast cancer	4.41e-06	6.62e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—breast cancer	4.29e-06	6.44e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—breast cancer	4.24e-06	6.36e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—breast cancer	4.23e-06	6.35e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Epirubicin—breast cancer	4.13e-06	6.19e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—breast cancer	4.12e-06	6.18e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—breast cancer	4.1e-06	6.15e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—breast cancer	4.1e-06	6.15e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—breast cancer	4.09e-06	6.14e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Epirubicin—breast cancer	4.02e-06	6.03e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Epirubicin—breast cancer	3.96e-06	5.95e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—breast cancer	3.96e-06	5.94e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Epirubicin—breast cancer	3.83e-06	5.75e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—breast cancer	3.82e-06	5.73e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—breast cancer	3.81e-06	5.71e-05	CcSEcCtD
Conjugated Estrogens—Rash—Methotrexate—breast cancer	3.77e-06	5.66e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—breast cancer	3.77e-06	5.66e-05	CcSEcCtD
Conjugated Estrogens—Headache—Methotrexate—breast cancer	3.75e-06	5.63e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Doxorubicin—breast cancer	3.72e-06	5.58e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Epirubicin—breast cancer	3.7e-06	5.56e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—breast cancer	3.67e-06	5.5e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Epirubicin—breast cancer	3.56e-06	5.34e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—breast cancer	3.55e-06	5.33e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—breast cancer	3.55e-06	5.32e-05	CcSEcCtD
Conjugated Estrogens—Rash—Epirubicin—breast cancer	3.53e-06	5.3e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—breast cancer	3.53e-06	5.29e-05	CcSEcCtD
Conjugated Estrogens—Headache—Epirubicin—breast cancer	3.51e-06	5.26e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Doxorubicin—breast cancer	3.43e-06	5.14e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Epirubicin—breast cancer	3.33e-06	4.99e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Doxorubicin—breast cancer	3.29e-06	4.94e-05	CcSEcCtD
Conjugated Estrogens—Rash—Doxorubicin—breast cancer	3.27e-06	4.9e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—breast cancer	3.26e-06	4.9e-05	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—breast cancer	3.25e-06	4.87e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Doxorubicin—breast cancer	3.08e-06	4.62e-05	CcSEcCtD
Conjugated Estrogens—ABCB1—Metabolism—BCHE—breast cancer	5.74e-07	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—breast cancer	5.73e-07	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ALB—breast cancer	5.69e-07	1.32e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA3—breast cancer	5.69e-07	1.32e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGFR1—breast cancer	5.68e-07	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC5A5—breast cancer	5.67e-07	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—breast cancer	5.65e-07	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC2A2—breast cancer	5.65e-07	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA4—breast cancer	5.63e-07	1.3e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CA9—breast cancer	5.63e-07	1.3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1B—breast cancer	5.63e-07	1.3e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIF1A—breast cancer	5.59e-07	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.59e-07	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CB—breast cancer	5.58e-07	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—breast cancer	5.54e-07	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CPT1A—breast cancer	5.53e-07	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—MTR—breast cancer	5.53e-07	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCG2—breast cancer	5.53e-07	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—breast cancer	5.53e-07	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GPX2—breast cancer	5.49e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA2—breast cancer	5.49e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC2A1—breast cancer	5.48e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NQO1—breast cancer	5.48e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CD—breast cancer	5.47e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—LEP—breast cancer	5.46e-07	1.26e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NOS3—breast cancer	5.44e-07	1.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HPGDS—breast cancer	5.43e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GPX4—breast cancer	5.42e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SULT1A1—breast cancer	5.42e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CAV1—breast cancer	5.41e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ALB—breast cancer	5.4e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HBA1—breast cancer	5.39e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KDR—breast cancer	5.35e-07	1.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP3A4—breast cancer	5.34e-07	1.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CTNNB1—breast cancer	5.32e-07	1.23e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—breast cancer	5.3e-07	1.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—IDH1—breast cancer	5.3e-07	1.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA1—breast cancer	5.3e-07	1.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTT1—breast cancer	5.26e-07	1.22e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ACHE—breast cancer	5.26e-07	1.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1B1—breast cancer	5.25e-07	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NAT2—breast cancer	5.24e-07	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.22e-07	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—breast cancer	5.19e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—breast cancer	5.18e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NOS3—breast cancer	5.17e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—HSP90AA1—breast cancer	5.15e-07	1.19e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FN1—breast cancer	5.15e-07	1.19e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NFKBIA—breast cancer	5.09e-07	1.18e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CD—breast cancer	5.07e-07	1.17e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOTCH1—breast cancer	5.04e-07	1.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CB—breast cancer	5.02e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NCOA1—breast cancer	5.01e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ALB—breast cancer	5e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP17A1—breast cancer	4.98e-07	1.15e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—breast cancer	4.98e-07	1.15e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—STK11—breast cancer	4.94e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP19A1—breast cancer	4.94e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS1—breast cancer	4.93e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO1—breast cancer	4.93e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CG—breast cancer	4.93e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APC—breast cancer	4.93e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KIT—breast cancer	4.93e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.91e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGF—breast cancer	4.87e-07	1.13e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.85e-07	1.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2D6—breast cancer	4.84e-07	1.12e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—breast cancer	4.82e-07	1.12e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SRC—breast cancer	4.81e-07	1.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NOS3—breast cancer	4.79e-07	1.11e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CB—breast cancer	4.77e-07	1.1e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA2—breast cancer	4.75e-07	1.1e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—breast cancer	4.73e-07	1.09e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—breast cancer	4.63e-07	1.07e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BRAF—breast cancer	4.63e-07	1.07e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—FASN—breast cancer	4.6e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MED12—breast cancer	4.59e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—DPYD—breast cancer	4.59e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—COMT—breast cancer	4.59e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—BCHE—breast cancer	4.58e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTP1—breast cancer	4.57e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC5A5—breast cancer	4.53e-07	1.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALDOA—breast cancer	4.52e-07	1.05e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IGF1—breast cancer	4.51e-07	1.04e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT2—breast cancer	4.51e-07	1.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—HMOX1—breast cancer	4.51e-07	1.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ITPR1—breast cancer	4.5e-07	1.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAPK3—breast cancer	4.43e-07	1.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CB—breast cancer	4.42e-07	1.02e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA3—breast cancer	4.39e-07	1.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—breast cancer	4.38e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NQO1—breast cancer	4.37e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC2A1—breast cancer	4.37e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC2A2—breast cancer	4.36e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—breast cancer	4.34e-07	1e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CD—breast cancer	4.33e-07	1e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—breast cancer	4.33e-07	1e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—breast cancer	4.33e-07	1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—breast cancer	4.31e-07	9.96e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TGFB1—breast cancer	4.3e-07	9.93e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MAPK3—breast cancer	4.29e-07	9.92e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SERPINE1—breast cancer	4.28e-07	9.91e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.28e-07	9.9e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CPT1A—breast cancer	4.27e-07	9.88e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MTR—breast cancer	4.27e-07	9.88e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCG2—breast cancer	4.27e-07	9.88e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP3A4—breast cancer	4.26e-07	9.86e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMS—breast cancer	4.25e-07	9.82e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.24e-07	9.81e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—breast cancer	4.21e-07	9.74e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NCOR1—breast cancer	4.2e-07	9.71e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PLA2G4A—breast cancer	4.2e-07	9.71e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTM1—breast cancer	4.2e-07	9.71e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1B1—breast cancer	4.19e-07	9.7e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HPGDS—breast cancer	4.19e-07	9.68e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—breast cancer	4.17e-07	9.64e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HBA1—breast cancer	4.16e-07	9.62e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—breast cancer	4.12e-07	9.54e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HSP90AA1—breast cancer	4.11e-07	9.51e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOS3—breast cancer	4.09e-07	9.46e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTT1—breast cancer	4.06e-07	9.39e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ACHE—breast cancer	4.06e-07	9.39e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GPX1—breast cancer	4.02e-07	9.3e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA1—breast cancer	4e-07	9.25e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1A1—breast cancer	3.98e-07	9.21e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—breast cancer	3.98e-07	9.2e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ERCC2—breast cancer	3.95e-07	9.13e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—STK11—breast cancer	3.94e-07	9.12e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP19A1—breast cancer	3.94e-07	9.12e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—breast cancer	3.91e-07	9.04e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—breast cancer	3.88e-07	8.98e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RAF1—breast cancer	3.87e-07	8.94e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RELA—breast cancer	3.85e-07	8.9e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP17A1—breast cancer	3.84e-07	8.89e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—breast cancer	3.83e-07	8.85e-06	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—breast cancer	3.82e-07	8.83e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO1—breast cancer	3.81e-07	8.8e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS1—breast cancer	3.81e-07	8.8e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CB—breast cancer	3.78e-07	8.73e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MTOR—breast cancer	3.78e-07	8.73e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2D6—breast cancer	3.73e-07	8.63e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—MTHFR—breast cancer	3.71e-07	8.58e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.7e-07	8.56e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—COMT—breast cancer	3.66e-07	8.48e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA2—breast cancer	3.66e-07	8.47e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—breast cancer	3.66e-07	8.45e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTP1—breast cancer	3.65e-07	8.44e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—breast cancer	3.63e-07	8.39e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HMOX1—breast cancer	3.6e-07	8.32e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ITPR1—breast cancer	3.59e-07	8.3e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—FASN—breast cancer	3.55e-07	8.22e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1B—breast cancer	3.54e-07	8.19e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BCHE—breast cancer	3.54e-07	8.18e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—breast cancer	3.54e-07	8.18e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC5A5—breast cancer	3.49e-07	8.08e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—breast cancer	3.47e-07	8.03e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—breast cancer	3.47e-07	8.02e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCB1—breast cancer	3.45e-07	7.99e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAV1—breast cancer	3.42e-07	7.92e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—breast cancer	3.4e-07	7.87e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMS—breast cancer	3.39e-07	7.84e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—breast cancer	3.38e-07	7.82e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—breast cancer	3.38e-07	7.82e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NQO1—breast cancer	3.38e-07	7.81e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC2A1—breast cancer	3.38e-07	7.81e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JUN—breast cancer	3.37e-07	7.8e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOR1—breast cancer	3.35e-07	7.75e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.35e-07	7.75e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTM1—breast cancer	3.35e-07	7.75e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CTNNB1—breast cancer	3.35e-07	7.74e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—breast cancer	3.28e-07	7.59e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—breast cancer	3.27e-07	7.56e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—breast cancer	3.26e-07	7.55e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—breast cancer	3.24e-07	7.49e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1B1—breast cancer	3.24e-07	7.48e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GPX1—breast cancer	3.21e-07	7.42e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK8—breast cancer	3.19e-07	7.38e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—breast cancer	3.19e-07	7.38e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1A1—breast cancer	3.18e-07	7.35e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.17e-07	7.34e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ERCC2—breast cancer	3.15e-07	7.29e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CG—breast cancer	3.12e-07	7.21e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA1—breast cancer	3.09e-07	7.14e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—breast cancer	3.06e-07	7.08e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—STK11—breast cancer	3.04e-07	7.04e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP19A1—breast cancer	3.04e-07	7.04e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SRC—breast cancer	3.03e-07	7e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—breast cancer	2.99e-07	6.91e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—MTHFR—breast cancer	2.96e-07	6.85e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—breast cancer	2.95e-07	6.82e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—breast cancer	2.92e-07	6.75e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—breast cancer	2.91e-07	6.73e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—breast cancer	2.89e-07	6.69e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—COMT—breast cancer	2.83e-07	6.54e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTP1—breast cancer	2.82e-07	6.51e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK3—breast cancer	2.79e-07	6.45e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—breast cancer	2.78e-07	6.43e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HMOX1—breast cancer	2.78e-07	6.42e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ITPR1—breast cancer	2.77e-07	6.41e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CD—breast cancer	2.74e-07	6.34e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAV1—breast cancer	2.73e-07	6.32e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—breast cancer	2.71e-07	6.27e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ALB—breast cancer	2.71e-07	6.26e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TGFB1—breast cancer	2.7e-07	6.26e-06	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—breast cancer	2.69e-07	6.23e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCB1—breast cancer	2.66e-07	6.16e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—breast cancer	2.65e-07	6.13e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMS—breast cancer	2.62e-07	6.05e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.61e-07	6.04e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NOS3—breast cancer	2.59e-07	5.99e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTM1—breast cancer	2.59e-07	5.98e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOR1—breast cancer	2.59e-07	5.98e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.59e-07	5.98e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—breast cancer	2.51e-07	5.79e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—breast cancer	2.5e-07	5.78e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CG—breast cancer	2.49e-07	5.76e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GPX1—breast cancer	2.48e-07	5.73e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1A1—breast cancer	2.45e-07	5.67e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ERCC2—breast cancer	2.43e-07	5.63e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CB—breast cancer	2.39e-07	5.53e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—breast cancer	2.38e-07	5.5e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—breast cancer	2.37e-07	5.47e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—breast cancer	2.3e-07	5.32e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MTHFR—breast cancer	2.29e-07	5.29e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—breast cancer	2.23e-07	5.15e-06	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—breast cancer	2.2e-07	5.09e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CD—breast cancer	2.19e-07	5.06e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ALB—breast cancer	2.16e-07	5e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—breast cancer	2.13e-07	4.93e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAV1—breast cancer	2.11e-07	4.88e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NOS3—breast cancer	2.07e-07	4.78e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—breast cancer	2.06e-07	4.77e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—breast cancer	2.04e-07	4.71e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CG—breast cancer	1.92e-07	4.44e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CB—breast cancer	1.91e-07	4.41e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—breast cancer	1.89e-07	4.37e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—breast cancer	1.88e-07	4.35e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CD—breast cancer	1.69e-07	3.91e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ALB—breast cancer	1.67e-07	3.86e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—breast cancer	1.65e-07	3.81e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NOS3—breast cancer	1.59e-07	3.69e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CB—breast cancer	1.47e-07	3.4e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—breast cancer	1.46e-07	3.37e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—breast cancer	1.46e-07	3.37e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—breast cancer	1.27e-07	2.94e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—breast cancer	1.19e-07	2.75e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—breast cancer	1.16e-07	2.69e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—breast cancer	9.5e-08	2.2e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—breast cancer	8.97e-08	2.08e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—breast cancer	7.33e-08	1.7e-06	CbGpPWpGaD
